Date: 2016-03-08
Type of information: Restructuring
Compound:
Company: Sarepta Therapeutics (USA - MA)
Therapeutic area: Rare diseases - Genetic diseases - Neuromuscular diseases
Type agreement: restructuring
Action mechanism:
Disease:
Details: * On March 8, 2016, Sarepta Therapeutics announced a long term plan to move all of the Company’s operations to Massachusetts, as part of a strategic plan to increase operational efficiency. Over the course of the year, the Company plans to close their facility in Corvallis, Oregon, which primarily focused on early-stage research and research manufacturing. As part of the consolidation, research activities and some employees will transition to Sarepta facilities in Andover and Cambridge, Massachusetts. The consolidation efforts are planned to occur in four waves – in May, October, November, and December of this year – with an estimated completion date of December 30, 2016.
Financial terms:
Latest news:
